Chronic pain influences approximately 20% with the inhabitants throughout the world, and many patients practical experience its detrimental effects on their quality of life and mental health. Ketamine, an NMDA antagonist that also functions on opioid receptors, has been examined as being a pharmacologic option for chronic pain conditions. RCTs have